About GlyTech
GlyTech is a company based in Kyoto (Japan) founded in 2012. GlyTech has raised $9.14 million across 2 funding rounds from investors including Yokogawa, Osaka University and Nippon Shokubai. GlyTech operates in a competitive market with competitors including Echelon Biosciences, Iceni Glycoscience, GlycoSpot, TFChem and ADDAX Biosciences, among others.
- Headquarter Kyoto, Japan
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$9.14 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Yokogawa
& 5 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of GlyTech
GlyTech has successfully raised a total of $9.14M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in GlyTech
GlyTech has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Yokogawa, Osaka University and Nippon Shokubai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funds are managed to support unlisted companies' growth.
|
Locked | Locked | Locked | |
|
Cloud-based industrial automation and process control solutions are offered.
|
Locked | Locked | Locked | |
|
Chemical catalysts and absorbents are manufactured by the company.
|
Locked | Locked | Locked |
Investor details for GlyTech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by GlyTech
Investment portfolio details for GlyTech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - GlyTech
Detailed financials for GlyTech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Glytech Comparisons
Peer comparison for GlyTech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of GlyTech
GlyTech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Echelon Biosciences, Iceni Glycoscience, GlycoSpot, TFChem and ADDAX Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and assays for lipid biology research are manufactured.
|
|
| Locked | Locked | Locked |
Glycoscience platform is provided for diagnostic and therapeutic applications.
|
|
| Locked | Locked | Locked |
High-throughput enzyme screening solutions are developed and provided.
|
|
| Locked | Locked | Locked |
Fluoride chemistry is utilized to design glycomimetic drug compounds.
|
|
| Locked | Locked | Locked |
Developer of a non-toxic formalin alternative tissue fixative. This fixative provides comparable or superior results to formalin in histological, immunohistochemical, and molecular analyses, while eliminating the carcinogenic and toxic risks associated with formalin use. The product is protected by an international patent and is designed for use in histology laboratories, improving both patient care and worker safety. The company collaborates with various research institutions to advance the application of this technology in different fields.
|
Detailed competitors of GlyTech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Glytech
Complete news archive for GlyTech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about GlyTech
GlyTech was founded in 2012 and raised its 1st funding round 6 years after it was founded.
GlyTech is headquartered in Kyoto, Japan. It is registered at Kyoto, Kyoto Prefecture, Japan.
Hiroaki Asai is the current CEO of GlyTech.
GlyTech is a funded company, having raised a total of $9.14M across 2 funding rounds to date.
GlyTech was established in 2012 in Kyoto, Japan, within the biotechnology sector. Human-type asparagine-linked glycans are provided for research purposes. Operations center on glycan production and chemical glycosylation technologies, which are applied to medicine development, including biopharmaceuticals and oligonucleotide therapeutics. The companys activities support advancements in these therapeutic areas through specialized glycan solutions.
GlyTech's top competitors include Echelon Biosciences, Iceni Glycoscience and GlycoSpot.
GlyTech has 6 investors. Key investors include Yokogawa, Osaka University, Nippon Shokubai, Fushimi Pharmaceutical, and Miat.